Overview
- Provides up-to-date information on cancer-related microRNA research, with focus on computational data analysis
- Focuses on the use of microRNAs in cancer diagnosis and treatment
- Includes contributions from internationally renowned clinicians and bioinformaticians from around the globe
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1385)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
-
Front Matter
Keywords
About this book
This book provides an update on the latest development in the field of microRNAs in cancer research with an emphasis on translational research.
Since the early 2000s, microRNAs have been recognized as important and ubiquitous regulators of gene expression. Soon it became evident that their deregulation can cause human diseases including cancer. This book focuses on the emerging opportunities for the application of microRNA research in clinical practice. In this context, computer models are presented that can help to identify novel biomarkers, e.g. in circulating microRNAs, and tools that can help to design microRNA-based therapeutic interventions. Other chapters evaluate the role of microRNAs in immunotherapy, immune responses and drug resistance.
Covering key topics on microRNAs in cancer research this book is a valuable resource for both emerging and established microRNA researchers who want to explore the potential of microRNAs as therapeutic targets or co-adjuvants in cancer therapies.
Editors and Affiliations
About the editors
Ulf Schmitz’s research focus is on RNA biology and systems medicine. He integrates in silico, in vitro and in vivo approaches in advanced interdisciplinary research. His team develops integrative systems medicine workflows along with tools and databases to identify and study interactions between RNAs and other molecules, mechanisms of gene regulation, and gene regulatory networks.
With the goal of achieving a deeper understanding of processes involved in disease emergence and progression, his projects focus on different cancer entities and possible avenues for therapeutic interventions and optimized treatment schedules.
Olaf Wolkenhauer's research combines data-driven modelling with model-driven experimentation, using a wide range of approaches, including machine learning, statistics, systems theory, and stochastic processes. He has extensive experience in developing systems theoretic concepts and developing algorithms, workflows,standards and software tools that support the analysis data with applications in biomedicine. A specific interest is in understanding the functioning of cells within a tissue and how such whole-part relationships can be used to identify principles underlying tissue (mal)functioning.
Julio Vera-González is a physicist working in medical systems biology since 2005. His expertise is in mathematical modelling, bioinformatics and network biology. He applies multi-criteria decision algorithms to patient classification and therapy assessment. His primary interest is the role of (non-coding) RNA regulation in the interplay between cancer and the immune system, as well as its impact on (immuno)therapy.
Bibliographic Information
Book Title: Systems Biology of MicroRNAs in Cancer
Editors: Ulf Schmitz, Olaf Wolkenhauer, Julio Vera-González
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-031-08356-3
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
Hardcover ISBN: 978-3-031-08355-6Published: 11 November 2022
Softcover ISBN: 978-3-031-08358-7Published: 12 November 2023
eBook ISBN: 978-3-031-08356-3Published: 09 November 2022
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: VII, 317
Number of Illustrations: 1 b/w illustrations
Topics: Cancer Research, Genetics and Genomics